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Cicatricial pemphygoid (mucous membrane cicatricial 
pemphygoid) is a chronic autoimmune inflammatory disease 
characterized by subepithelial bubbles in mucous membranes 
and, occasionally on the skin. It may affect the mouth, the 
nose, pharynx, larynx, the eyes, esophagus, anus, genitals 
and skin; especially affecting patients between fifty and 
sixty years of life. Treatment includes systemic steroids and 
immunosuppressive agents. In the present paper we describe 
two cases with the active disease, and one of them had sepsis 
because of using immunosuppressive agents and another 
that presented supraglottic stenosis requiring tracheostomy.
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INTRODUCTION
Cicatricial pemphigoid, also known as mucous 
membrane cicatricial pemphigoid, is a rare autoimmune 
disease of chronic development that involves mainly 
mucous membranes with the formation of subepithelial 
blisters. Subjects in older age groups (mean 70 years) are 
predominantly affected, although cases involving younger 
patients have been reported. This disease is uncommon 
among non-Caucasians, and is more frequently found in 
men1-4.
Diagnosis requires observation of typical clinical 
manifestations and pathology tests indicating the presence 
of linear immune deposits of IgG, IgA, and/or C3 on the 
epithelial basal membrane1.
Few publications in the literature describe this di-
sease from the standpoint of otorhinolaryngology. Most 
papers report on ophthalmic and dermatologic cases. The 
most frequent therapies are cyclophosphamide combined 
with prednisone for high risk patients (defined here in a 
simplified manner as presence of ocular, genital, naso-
pharyngeal, esophageal, or laryngeal involvement) and 
dapsone for less severe cases1,4. Azathioprine was also con-
sidered as an option for high risk cases in spite of reports 
mentioning disease exacerbation consequent to its use 3. 
Subconjunctival mitomycin-C has also been described in 
cicatricial pemphigoid eye lesions5.
Cicatricial pemphigoid combined with laryngeal 
involvement must be initially treated clinically, as surgery 
should be reserved for more severe cases with airway 
obstruction due to frequent disease recurrence6.
CASE REPORT
Case 1
J.R.S., 52, brown, driver. The patient started having 
repetition epistaxis six years ago, along with nasal obstruc-
tion and weight loss. The patient lost 18 kilograms in one 
year. He claimed not to have had other diseases previously. 
He had granulous nasal septum and synechia obstructing 
80% of the left nasal fossa, apart from granulation in the 
soft palate. Biopsy was done on septal mucosa and palate 
tissue. Alcohol-acid resistant bacteria tests and chest x-
rays were normal. Pathology tests indicated the presence 
of amastigote Leishmania sp. The patient was sent to the 
department of infectious diseases and was treated with two 
cycles of Glucantime and then amphotericin B, with no 
improvement. Bullous lesions and ulcers on the left elbow 
and lower limbs began to appear, and the Dermatology 
Department indicated the patient could have cicatricial 
pemphigoid combined with cutaneous leishmaniasis.
About a year after the first visit, the patient came 
back with jugal mucosa lesions, and pemphigus vulgaris 
was also considered. The patient had been followed by 
the ophthalmology service to treat a non-specific chronic 
conjunctivitis, and cicatricial pemphigoid was once again 
considered.
Treatment with steroids was started as ocular and 
oral lesions persisted.
The following month oral lesions were found by 
the dermatology service, and azathioprine combined with 
prednisone was administered. Two months later the oral 
lesions were gone, but the patient had active eye disease 
despite the increase on the dosage of immunosuppressive 
medication kept for about ten months. The patient stopped 
taking azathioprine and started with cyclophosphamide.
Five months after he began taking the new medi-
cation, the patient developed severe complications as a 
result of chronic immunosuppressant and steroid therapy 
(cerebellar abscess, meningitis, lymphadenopathy with 
effusion, herpes zoster, and costal arch, humerus, and 
lumbar vertebrae pathologic fracture) and had to be hos-
pitalized for about three months. During hospitalization 
cyclophosphamide was stopped and prednisone doses 
were decreased. The patient was discharged as the lesions 
disappeared, with however reduced visual acuity.
In the last two years he had cataract in the left eye 
and nasal synechia. Tests (nasal fibroscopy and compu-
terized tomography) showed synechia in the left nasal 
fossa and no granulation in the mucosa. The patient is 
currently not taking any medication and is in otorhino-
laryngological review. In March of 2004 he had no signs 
of active disease.
 
Case 2
T.M.S., 78, Caucasian. The patient began experien-
cing painful, bullous lesions in the oral cavity thirteen years 
ago, compromising food intake and leading the patient to 
lose 21 kilograms in three months. The patient went to a 
series of specialized care providers but remained undiag-
nosed. She had been operated previously for glaucoma 
and cataract. Months after the onset of the oral lesions 
she had ophthalmic complications and was suspected for 
conjunctival inflammation secondary to a foreign body 
(surgical suture). In a subsequent visit the patient had a 
more exuberant disease and was suspected for cicatricial 
pemphigoid.
About 18 months after the lesions appeared, she 
was being followed at the dermatology service and star-
ted taking thalidomide only to partially improve. Next, 
prednisone was added. She was in remission for another 
two months and then stopped taking thalidomide. Back 
then her diagnosis was undefined, and in a visit with an 
ophthalmologist cicatricial pemphigoid was once again 
considered. An ENT assessment done in August of 1993 
showed bullous lesions in the oral cavity and granulation 
in the left nasal fossa.
In 1996, five years after symptom onset, the patient’s 
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ophthalmic complications were in remission and she had 
no high digestive tract lesions.
In 1999 she started taking an immunosuppressant 
(azathioprine) and reduced her steroid dosage. In 2003, 
dapsone was added to azathioprine and prednisone. The 
patient then started having frequent dyspnea episodes. 
She was sent to the pneumology service and spirometry 
tests indicated she had a high respiratory obstruction. She 
was then sent to the ENT service, where stenosis in the 
left nostril was found (Fig. 1), nasal crust to the right and 
bullous/vesicular lesions in the nasal septum mucosa; soft 
Tracheostomy was performed and her dyspnea improved. 
Six months elapsed between the onset of the dyspnea epi-
sodes and the tracheostomy. Today, in August of 2004, the 
patient is tracheostomized and without oral cavity lesions. 
She is taking azathioprine, prednisone, and dapsone.
DISCUSSION
This is a rare condition that involves the oral cavity 
(100%), followed by the eyes (61-80%), pharynx (43%), 
nose (38%), larynx (30%), genitalia (20-30%), rectum (11%), 
esophagus (7%) and sometimes the skin (10-43%)10. Eye 
lesions may evolve to blindness, while upper airway in-
volvement may lead to obstruction. Steroid therapy, when 
employed, may also introduce eye disorders. Our patients 
developed the most frequently found lesions, and had no 
skin, genitalia, or digestive tract involvement. As seen in 
both cases, diagnosis can be tricky and differentiation is 
required from a number of conditions, thus requiring a 
multidisciplinary approach. Both cases required a number 
of biopsies before a definitive diagnosis could be produced 
(clinical history and immunohistopathology tests). Biop-
sies were done using a cup forceps. Clinical treatment is 
paramount in preventing recurrence. However, patients 
are mostly older and susceptible to drug adverse effects. 
The first patient was treated with cyclophosphamide and 
prednisone after taking other immunosuppressant drugs 
and was in remission, despite some severe complications. 
The patient was in complete remission, i.e., with improved 
quality-of-life, no longer hospitalized, and had synechia 
in the left nasal fossa. She had no need for surgery due 
to the residual post-remission manifestations (’scars’), as 
they were quite modest. She had left eye cataract, thus 
stressing the need for multidisciplinary complication care. 
The second case was and elderly Caucasian female. She 
was initially treated with thalidomide and prednisone, and 
is now taking azathioprine, prednisone, and dapsone. Her 
disease is still active and she is tracheostomized due to 
obstructive complications. Cyclophosphamide combined 
with prednisone is the first choice therapy to reduce supra-
glottal stenosis and promote disease remission (high risk 
cases), although the patient was clinically stable given the 
tracheostomy, which at first is there to resolve her respira-
tory problems. Mitomycin-C could have been used as an 
alternative to treat active eye lesions, and would possibly 
be effective against airway stenosis. Inducing disease re-
mission is fundamental, thus avoiding the need for surgical 
intervention as well as periodic assessment to prevent 
recurrence, and disease and treatment complications.
CONCLUSION
Mucous membrane cicatricial pemphigoid must be 
considered when bullous chronic or cicatricial lesions in-
volve the oral mucosa at first, followed by the pharyngeal, 
Figure 1. Nasal cavity stenosis
Figure 2. Supraglottal stenosis
palate blisters/vesicles and cicatricial lesions in the soft 
and hard palate. Indirect laryngoscopy showed a thicke-
ned epiglottis; her vocal chords could not be visualized. 
Nasal fibroscopy showed extensive membrane-shaped 
supraglottal stenosis with an orifice of about 5 millimeters 
close to the glottis (Fig. 2). The glottis was not involved. 
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nasal, and laryngeal mucosa, mainly of elderly patients. 
ENT examination and nasal fibroscopy to periodically as-
sess lesions (activity/remission) and detect complications 
(stenosis, synechia) are required. Early diagnosis and 
treatment are useful in preventing complications.
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